Ying Lin
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 23
- MicroRNA in disease regulation 9
- Oncology 46
- Cancer Risks and Factors 10
- Cancer Immunotherapy and Biomarkers 9
- Chemokine receptors and signaling 8
- Co-authors
- Sherven P. Sharma (16 shared papers)Steven M. Dubinett (16 shared papers)Yunhui Cheng (4 shared papers)Jian Yang (4 shared papers)Chunxiang Zhang (4 shared papers)Xiaojun Liu (4 shared papers)Mariam Dohadwala (12 shared papers)Jie Luo (11 shared papers)
- Journals
- Cancer Letters (6 papers)Cancer Research (6 papers)Journal of Biological Chemistry (4 papers)International Journal of Cancer (3 papers)EClinicalMedicine (3 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ying Lin
215 papers receiving 8.8k citations
Ying Lin's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 2.1k
- Oncology 1.5k
- Immunology 1.2k
- Pharmacology 884
- Molecular Biology 1.7k
Countries citing papers authored by Ying Lin
This map shows the geographic impact of Ying Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lin more than expected).
Fields of papers citing papers by Ying Lin
This network shows the impact of papers produced by Ying Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lin. The network helps show where Ying Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 585 | |
| 2 | 2005 | 493 | |
| 3 | 2009 | 489 | |
| 4 | 2000 | 415 | |
| 5 | 2009 | 334 | |
| 6 | 2006 | 240 | |
| 7 | 2019 | 228 | |
| 8 | 2002 | 222 | |
| 9 | 2009 | 208 | |
| 10 | 2001 | 206 | |
| 11 | Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. | 2003 | 202 |
| 12 | 1999 | 197 | |
| 13 | 2001 | 197 | |
| 14 | 2017 | 194 | |
| 15 | 2004 | 184 | |
| 16 | 2020 | 162 | |
| 17 | 2008 | 125 | |
| 18 | 2003 | 124 | |
| 19 | Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study Hit paper breakdown → | 2023 | 121 |
| 20 | 2004 | 116 |
About Ying Lin
Ying Lin is a scholar working on Cancer Research, Oncology, Pharmacology, Immunology and Genetics, having authored 232 papers that have together received 9.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer Risks and Factors (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), MicroRNA in disease regulation (9 papers), Chemokine receptors and signaling (8 papers), Inflammatory mediators and NSAID effects (8 papers), Genetic Associations and Epidemiology (8 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.5k citations), Immunology (1.2k citations), Pharmacology (884 citations) and Molecular Biology (1.7k citations). Ying Lin has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Sherven P. Sharma, Steven M. Dubinett, Yunhui Cheng, Jian Yang, Chunxiang Zhang, Xiaojun Liu, Mariam Dohadwala, Jie Luo, Shuo Zhang and Ruochun Huang. Their work appears in journals such as Cancer Letters, Cancer Research, Journal of Biological Chemistry, International Journal of Cancer and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.